134 related articles for article (PubMed ID: 3105913)
1. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.
Gold HK; Johns JA; Leinbach RC; Yasuda T; Grossbard E; Zusman R; Collen D
Circulation; 1987 Jun; 75(6):1192-9. PubMed ID: 3105913
[TBL] [Abstract][Full Text] [Related]
2. Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial.
Williams DO; Topol EJ; Califf RM; Roberts R; Mancini GB; Joelson JM; Ellis SG; Kleiman NS
Circulation; 1990 Aug; 82(2):376-83. PubMed ID: 2115407
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina.
Nicklas JM; Topol EJ; Kander N; O'Neill WW; Walton JA; Ellis SG; Gorman L; Pitt B
J Am Coll Cardiol; 1989 Feb; 13(2):434-41. PubMed ID: 2492325
[TBL] [Abstract][Full Text] [Related]
4. Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial.
Topol EJ; Nicklas JM; Kander NH; Walton JA; Ellis SG; Gorman L; Pitt B
Am J Cardiol; 1988 Sep; 62(7):368-71. PubMed ID: 2970776
[TBL] [Abstract][Full Text] [Related]
5. Recombinant tissue-type plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectoris.
Ardissino D; Barberis P; De Servi S; Mussini A; Rolla A; Visani L; Specchia G
Am J Cardiol; 1990 Oct; 66(12):910-4. PubMed ID: 2121016
[TBL] [Abstract][Full Text] [Related]
6. Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo.
Freeman MR; Langer A; Wilson RF; Morgan CD; Armstrong PW
Circulation; 1992 Jan; 85(1):150-7. PubMed ID: 1728444
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous thrombolysis by recombinant plasminogen activator (rt-PA) in unstable angina. A randomized multicenter study versus placebo].
Charbonnier B; Bernadet P; Schiele F; Thery C; Baudouy M; Bauters C
Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1471-7. PubMed ID: 1297297
[TBL] [Abstract][Full Text] [Related]
8. Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator.
Johns JA; Gold HK; Leinbach RC; Yasuda T; Gimple LW; Werner W; Finkelstein D; Newell J; Ziskind AA; Collen D
Circulation; 1988 Sep; 78(3):546-56. PubMed ID: 3136953
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic therapy for unstable angina pectoris: rationale and results.
Gold HK; Johns JA; Leinbach RC; Yasuda T; Collen D
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):91B-95B. PubMed ID: 3117861
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator in refractory unstable angina. A randomized double-blind placebo-controlled trial in patients with refractory unstable angina and subsequent angioplasty.
van den Brand M; van Zijl A; Geuskens R; de Feyter PJ; Serruys PW; Simoons ML
Eur Heart J; 1991 Nov; 12(11):1208-14. PubMed ID: 1782951
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator using a rapid-infusion low-dose regimen for unstable angina.
Chaudhary H; Crozier I; Hamer A; Foy S; Shirlaw T; Ikram H
Am J Cardiol; 1992 Jan; 69(3):173-5. PubMed ID: 1731454
[TBL] [Abstract][Full Text] [Related]
12. Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate.
Verstraete M; Arnold AE; Brower RW; Collen D; de Bono DP; De Zwaan C; Erbel R; Hillis WS; Lennane RJ; Lubsen J
Am J Cardiol; 1987 Aug; 60(4):231-7. PubMed ID: 3113222
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction.
Topol EJ; O'Neill WW; Langburd AB; Walton JA; Bourdillon PD; Bates ER; Grines CL; Schork AM; Kline E; Pitt B
Circulation; 1987 Feb; 75(2):420-8. PubMed ID: 2948735
[TBL] [Abstract][Full Text] [Related]
14. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.
TIMI Study Group
N Engl J Med; 1989 Mar; 320(10):618-27. PubMed ID: 2563896
[TBL] [Abstract][Full Text] [Related]
15. Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial.
Gottlieb SO; Weisfeldt ML; Ouyang P; Achuff SC; Baughman KL; Traill TA; Brinker JA; Shapiro EP; Chandra NC; Mellits ED
Circulation; 1986 Feb; 73(2):331-7. PubMed ID: 3510764
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of prolonged low dose recombinant tissue-type plasminogen activator for refractory unstable angina.
Romeo F; Rosano GM; Martuscelli E; Comito M; Cardona N; Colistra C; Milano B; Bianco C; Rosano V
J Am Coll Cardiol; 1995 May; 25(6):1295-9. PubMed ID: 7722124
[TBL] [Abstract][Full Text] [Related]
17. Effects of thrombolytic therapy in unstable angina: clinical and angiographic results.
de Zwaan C; Bar FW; Janssen JH; de Swart HB; Vermeer F; Wellens HJ
J Am Coll Cardiol; 1988 Aug; 12(2):301-9. PubMed ID: 3134480
[TBL] [Abstract][Full Text] [Related]
18. Intracoronary recombinant tissue-type plasminogen activator in unstable angina: a pilot angiographic study.
DiSciascio G; Kohli RS; Goudreau E; Sabri N; Vetrovec GW
Am Heart J; 1991 Jul; 122(1 Pt 1):1-6. PubMed ID: 1905873
[TBL] [Abstract][Full Text] [Related]
19. Double-blind randomized trial of alteplase versus placebo in patients with chest pain at rest.
Roberts MJ; McNeill AJ; Dalzell GW; Wilson CM; Webb SW; Khan MM; Patterson GC; Adgey AA
Eur Heart J; 1993 Nov; 14(11):1536-42. PubMed ID: 8299637
[TBL] [Abstract][Full Text] [Related]
20. Thrombolysis with recombinant human tissue-type plasminogen activator during instability in coronary artery disease: effect on myocardial ischemia and need for coronary revascularization. TRIC Study Group.
Karlsson JE; Berglund U; Björkholm A; Ohlsson J; Swahn E; Wallentin L
Am Heart J; 1992 Dec; 124(6):1419-26. PubMed ID: 1462894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
